C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features
Melchior Chabannes, Sophie Chauvet(Assistance Publique – Hôpitaux de Paris), Carole Philipponnet(Université Clermont Auvergne), Jérôme Olagne(Université de Strasbourg), Alexandre Karras(Délégation Paris 5), Véronique Frémeaux‐Bacchi(Assistance Publique – Hôpitaux de Paris), Éric Daugas, Marion Rabant(Hôpital Necker-Enfants Malades), Sophie Ferlicot(Université Paris-Sud), David Buob(Inserm), Sophie Caillard(Hôpitaux Universitaires de Strasbourg), Marie‐Agnès Dragon‐Durey(Centre de Recherche des Cordeliers), Vincent Audard(Inserm), Carine El Sissy(Hôpital Européen), Thomas Crépin, Frank Bridoux(Université de Poitiers), Marie-Sophie Meuleman(Inserm), Éric Thervet(Hôpital Européen Georges-Pompidou), Paula Vieira Martins(Assistance Publique – Hôpitaux de Paris), Christine Kandel
Cited by 7
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
|American Journal of Transplantation|2016|625